Amgen: Biotech Giant's Path to Growth and Recovery
Amgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
A concise starter checklist for beginners to organize money, set goals, and monitor progress month by month.
16,693 articlesAmgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
OpenAI moves to turn ChatGPT into a multi‑tool platform ahead of a likely IPO this year. The plan centers on a broad ...
Eli Lilly is shaking up its growth plan by expanding beyond obesity with new infectious disease initiatives. This art...
A casual farm moment turns into a masterclass in budget-friendly self-care. Learn practical steps to embrace natural ...
Global inflation roars back globally as energy markets tighten amid geopolitical tensions, threatening budgets and co...
A three-judge panel affirmed the 25-year sentence for Sam Bankman-Fried in the FTX fraud case and denied his bid for ...
A three-brand furniture group projected a budgeted $180 million year, but the Ukraine war pushed the year into the re...
As Congress stalls on federal AI regulation, states are advancing targeted laws on chatbot interactions, employer use...
Prediction markets offer a different lens on big corporate moves. Discover what kalshi traders chance spacex says abo...
A major policy move in Japan raised rates to a level not seen in decades, but the crypto market barely moved. Learn w...
Bed Bath & Beyond is expanding beyond retail into real estate and homeowner services with a $53.38 million all-stock ...
A Bloomberg-sparked rumor could change how AI compute is bought and sold. If Amazon starts selling its custom AI chip...